By Editor • September 3, 2026 • 1 min read
The FDA has surprisingly made progress against unproven stem cell treatments, despite concerns raised by Robert F. Kennedy Jr.'s admissions.
Read moreBy Editor • September 1, 2026 • 1 min read
The Trump administration's announcement of drug pricing deals raises significant unanswered questions about their implications.
Read moreBy Editor • September 1, 2026 • 1 min read
The Trump administration has exacerbated bureaucratic challenges in health care and science, increasing the 'time tax' on Americans.
Read moreBy Editor • August 31, 2026 • 1 min read
GLP-1 medications are prompting a significant reevaluation of health care expenses by employers.
Read moreBy Editor • August 24, 2026 • 1 min read
Aon forecasts a tough 2027 for job-based health premiums, urging employers to seek better data amid rising costs.
Read moreBy Editor • August 19, 2026 • 1 min read
Epic's annual meeting featured new EHR clients and creative musical tributes, raising questions about the song selection process.
Read moreBy Editor • August 18, 2026 • 1 min read
Major health care executives in Massachusetts saw significant salary increases in 2024 amid rising operational challenges.
Read moreBy Editor • August 18, 2026 • 1 min read
Government workers are facing intensified health care challenges as states approach a crucial deadline for a federal drug pricing program.
Read moreBy Editor • August 17, 2026 • 1 min read
Last week, the Trump administration made significant moves in health care, from vaccine policy changes to scrutiny of private equity in the sector.
Read more
